See more : Tonymoly Co., Ltd (214420.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Komipharm International Co., Ltd. (041960.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Komipharm International Co., Ltd., a leading company in the industry within the sector.
You may be interested
- Cocolonet CO., LTD. (6060.T) Income Statement Analysis – Financial Results
- Beard Co. (The) (BRCOQ) Income Statement Analysis – Financial Results
- Besqab AB (publ) (BESQ.ST) Income Statement Analysis – Financial Results
- Palmer Square Capital BDC Inc. (PSBD) Income Statement Analysis – Financial Results
- Steelcast Limited (STEELCAS.BO) Income Statement Analysis – Financial Results
Komipharm International Co., Ltd. (041960.KQ)
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 42.65B | 39.80B | 35.85B | 37.16B | 35.49B |
| Cost of Revenue | 29.99B | 28.34B | 24.61B | 23.78B | 24.16B |
| Gross Profit | 12.66B | 11.46B | 11.23B | 13.38B | 11.33B |
| Gross Profit Ratio | 29.68% | 28.79% | 31.34% | 36.00% | 31.92% |
| Research & Development | 5.94B | 2.54B | 5.12B | 3.27B | 4.65B |
| General & Administrative | 1.81B | 1.61B | 1.53B | 1.50B | 258.02M |
| Selling & Marketing | 2.87B | 2.69B | 2.01B | 2.24B | 2.02B |
| SG&A | 4.68B | 4.29B | 3.54B | 3.74B | 10.10B |
| Other Expenses | 8.31B | -2.89B | -561.86M | -322.89M | 0.00 |
| Operating Expenses | 18.93B | 15.26B | 16.52B | 15.55B | 23.66B |
| Cost & Expenses | 48.92B | 43.60B | 41.14B | 39.34B | 47.82B |
| Interest Income | 678.36M | 227.68M | 140.21M | 165.33M | 391.98M |
| Interest Expense | 2.55B | 2.22B | 1.66B | 1.55B | 1.91B |
| Depreciation & Amortization | 3.53B | 3.83B | 3.58B | 3.74B | 3.86B |
| EBITDA | 341.75M | -1.44B | -1.00B | 1.33B | -1.58B |
| EBITDA Ratio | 0.80% | -5.45% | -2.79% | 3.20% | -4.44% |
| Operating Income | -6.27B | -3.80B | -5.29B | -2.17B | -5.43B |
| Operating Income Ratio | -14.71% | -9.56% | -14.76% | -5.85% | -15.31% |
| Total Other Income/Expenses | 533.63M | -3.68B | -643.66M | -1.78B | -8.42B |
| Income Before Tax | -5.74B | -7.48B | -5.93B | -3.96B | -13.85B |
| Income Before Tax Ratio | -13.46% | -18.79% | -16.55% | -10.65% | -39.03% |
| Income Tax Expense | 171.15M | -3.16B | -767.34M | -1.52B | 9.42B |
| Net Income | -3.98B | -6.51B | -4.46B | -2.82B | -21.36B |
| Net Income Ratio | -9.33% | -16.37% | -12.44% | -7.58% | -60.20% |
| EPS | -57.00 | -84.49 | -63.60 | -40.08 | -305.45 |
| EPS Diluted | -57.00 | -84.49 | -63.60 | -40.08 | -305.39 |
| Weighted Avg Shares Out | 69.81M | 77.09M | 70.12M | 70.25M | 69.94M |
| Weighted Avg Shares Out (Dil) | 69.81M | 77.09M | 70.12M | 70.25M | 69.95M |
No news found for: 041960.KQ
Source: https://incomestatements.info
Category: Stock Reports